Business Context and Reporting Period
This Form 8-K filing by Cardinal Health, Inc. (CAH) was submitted on August 4, 2026. The report discloses a material executive appointment within the company's finance leadership team.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on personnel changes and associated compensation arrangements.
Material Changes
The primary material change reported is the appointment of Anita Zielinski as Chief Accounting Officer, effective November 5, 2026. She will succeed Mary Scherer, who will serve in the role until the transition date. Ms. Zielinski will initially join as Senior Vice President of Finance on September 16, 2026.
Management Commentary and Compensation
Ms. Zielinski brings extensive experience from Baxter International, Inc., where she served as interim CFO and Chief Accounting Officer, and previously from Sysco Corporation, where she held CFO and Chief Accounting Officer roles. Her compensation package includes:
- Annual base salary.
- Annual cash bonus under the Management Incentive Plan.
- Annual equity-based awards under the long-term incentive program.
- A cash sign-on bonus of $750,000 to address compensation forfeited at her former employer.
- An initial grant of time-vesting restricted share units with a grant date value of $1,000,000, vesting ratably over three years.
The filing states there are no family relationships with directors or officers and no undisclosed arrangements regarding her selection.
Investor Verification Checklist
- Verify the exact start dates for Ms. Zielinski's roles as Senior Vice President of Finance (September 16, 2026) and Chief Accounting Officer (November 5, 2026).
- Confirm the vesting schedule and terms of the $1,000,000 restricted share unit grant.
- Review the transition plan for Mary Scherer's departure from the Chief Accounting Officer role.
- Assess the impact of the $1.75 million in immediate compensation (sign-on bonus and RSU value) on the company's near-term expense recognition.